David M. Kendall

David M.
Kendall currently works at Zealand Pharma A, as Chief Medical Officer from 2022.
Dr. Kendall also formerly worked at Amylin Pharmaceuticals, Inc., as Medical Director from 2005 to 2008, Park Nicollet Health Services, as Director & Medical Director from 1994 to 1997, International Diabetes Center, as Medical Director from 1997 to 2009, Eli Lilly & Co., as Vice President-Global Medical Affairs from 2011 to 2018, MannKind Corp., as Chief Medical Officer from 2018 to 2020, American Diabetes Association, as Chief Scientific & Medical Affairs Officer from 2009 to 2011, and Lilly Diabetes, as Vice President-Global Medical Affairs from 2011 to 2018.
Dr. Kendall received his undergraduate degree in 1983 from St. Olaf College and doctorate degree in 1988 from the University of Minnesota.